<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Precision Oncology Theranostics &#8211; BIOENGINEER.ORG</title>
	<atom:link href="https://bioengineer.org/tag/precision-oncology-theranostics/feed/" rel="self" type="application/rss+xml" />
	<link>https://bioengineer.org</link>
	<description>Bioengineering</description>
	<lastBuildDate>Sat, 06 Sep 2025 10:01:04 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.0</generator>

<image>
	<url>https://bioengineer.org/wp-content/uploads/2019/09/cropped-bioengineering-32x32.png</url>
	<title>Precision Oncology Theranostics &#8211; BIOENGINEER.ORG</title>
	<link>https://bioengineer.org</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">72741379</site>	<item>
		<title>Inside the August 1, 2025 Ahead-of-Print: The Journal of Nuclear Medicine Highlights</title>
		<link>https://bioengineer.org/inside-the-august-1-2025-ahead-of-print-the-journal-of-nuclear-medicine-highlights/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Fri, 01 Aug 2025 16:51:38 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[CD24-targeted Radiotracers]]></category>
		<category><![CDATA[Mitochondrial Dysfunction in Friedreich Ataxia]]></category>
		<category><![CDATA[Molecular Imaging Innovations]]></category>
		<category><![CDATA[Precision Oncology Theranostics]]></category>
		<category><![CDATA[Prostate Cancer Metastasis Heterogeneity]]></category>
		<guid isPermaLink="false">https://bioengineer.org/inside-the-august-1-2025-ahead-of-print-the-journal-of-nuclear-medicine-highlights/</guid>

					<description><![CDATA[Reston, VA (August 1, 2025)—In a groundbreaking advance for nuclear medicine and molecular imaging, the latest ahead-of-print articles published by The Journal of Nuclear Medicine (JNM) detail promising innovations that could vastly enhance cancer detection, monitoring, and the understanding of neurodegenerative cardiac complications. These studies, rooted in sophisticated positron emission tomography (PET) methodologies, showcase the [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">252481</post-id>	</item>
	</channel>
</rss>
